Abnormal uterine bleeding
Conditions
Interventions
Group Remimazolam(Group R):Remimazolam+Remifentanil
Group Ciprofol(Group C):Ciprofol+Remifentanil
Sponsors
Mengcheng County No. 1 People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria 1. Patients undergoing elective hysteroscopy; 2. Age 18-65 years old; 3. ASA is classified as Grade I-II; 4. BMI 18-30 kg/m2 5. Able to understand and complete the questionnaire with the assistance of medical staff; 6. Voluntarily participate in the trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Mental illness, Disorders of consciousness or inability to communicate; 2. Have a history of allergy to Narcotic and Contraindication of remiazolam and cyclopol; 3. Taking Antidepressant, Anxiolytic or other psychotropic drugs for a long time (more than 3 months); 4. Unable to understand or refuse to complete the questionnaire;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PAS-7;VAS-A; | — |
Secondary
| Measure | Time frame |
|---|---|
| Demography information and surgical information;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactXiaoqiang Zhang
Mengcheng County No. 1 People’s Hospital
Outcome results
None listed